Neuropathology provides clues to the pathophysiology of Gaucher disease - PubMed (original) (raw)
Comparative Study
. 2004 Jul;82(3):192-207.
doi: 10.1016/j.ymgme.2004.04.011.
Affiliations
- PMID: 15234332
- DOI: 10.1016/j.ymgme.2004.04.011
Comparative Study
Neuropathology provides clues to the pathophysiology of Gaucher disease
Kondi Wong et al. Mol Genet Metab. 2004 Jul.
Abstract
To better understand the pathogenesis of brain dysfunction in Gaucher disease (GD), we studied brain pathology in seven subjects with type 1 GD (four also exhibited parkinsonism and dementia), three with type 2 GD and four with type 3 GD. Unique pathologic patterns of disease involving the hippocampal CA2-4 regions and layer 4b of the calcarine cortex were identified. While these findings were common to all three GD phenotypes, the extent of the changes varied depending on the severity of disease. Cerebral cortical layers 3 and 5, hippocampal CA2-4, and layer 4b were involved in all GD patients. Neuronal loss predominated in both type 2 and type 3 patients with progressive myoclonic encephalopathy, whereas patients classified as type 1 GD had only astrogliosis. Adjacent regions and lamina, including hippocampal CA1 and calcarine lamina 4a and 4c were spared of pathology, highlighting the specificity of the vulnerability of selective neurons. Elevated glucocerebrosidase expression by immunohistochemistry was found in CA2-4. Hippocampal (45)Ca(2+) uptake autoradiography in rat brain was performed demonstrating that hippocampal CA2-4 neurons, rather than CA1 neurons, were calcium-induced calcium release sensitive (CICR-sensitive). These findings match recent biochemical studies linking elevated glucosylceramide levels to sensitization of CA2-4 RyaR receptors and 300% potentiation of neuronal CICR sensitivity. In two patients with type 1 GD and parkinsonism, numerous synuclein positive inclusions, similar to brainstem-type Lewy bodies found in Parkinson disease, were also found hippocampal CA2-4 neurons. These findings argue for a common cytotoxic mechanism linking aberrant glucocerebrosidase activity, neuronal cytotoxicity, and cytotoxic Lewy body formation in GD.
Similar articles
- Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism.
Furderer ML, Hertz E, Lopez GJ, Sidransky E. Furderer ML, et al. Int J Mol Sci. 2022 May 23;23(10):5842. doi: 10.3390/ijms23105842. Int J Mol Sci. 2022. PMID: 35628652 Free PMC article. Review. - Tuft-shaped astrocytes in Lewy body disease.
Hishikawa N, Hashizume Y, Yoshida M, Niwa J, Tanaka F, Sobue G. Hishikawa N, et al. Acta Neuropathol. 2005 Apr;109(4):373-80. doi: 10.1007/s00401-004-0967-3. Epub 2005 Jan 25. Acta Neuropathol. 2005. PMID: 15668789 - Gaucher disease: complexity in a "simple" disorder.
Sidransky E. Sidransky E. Mol Genet Metab. 2004 Sep-Oct;83(1-2):6-15. doi: 10.1016/j.ymgme.2004.08.015. Mol Genet Metab. 2004. PMID: 15464415 Review. - Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease.
Farfel-Becker T, Vitner EB, Pressey SN, Eilam R, Cooper JD, Futerman AH. Farfel-Becker T, et al. Hum Mol Genet. 2011 Apr 1;20(7):1375-86. doi: 10.1093/hmg/ddr019. Epub 2011 Jan 20. Hum Mol Genet. 2011. PMID: 21252206 - Enhanced calcium release in the acute neuronopathic form of Gaucher disease.
Pelled D, Trajkovic-Bodennec S, Lloyd-Evans E, Sidransky E, Schiffmann R, Futerman AH. Pelled D, et al. Neurobiol Dis. 2005 Feb;18(1):83-8. doi: 10.1016/j.nbd.2004.09.004. Neurobiol Dis. 2005. PMID: 15649698
Cited by
- The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease.
Collins LM, Williams-Gray CH. Collins LM, et al. Front Psychiatry. 2016 May 20;7:89. doi: 10.3389/fpsyt.2016.00089. eCollection 2016. Front Psychiatry. 2016. PMID: 27242557 Free PMC article. Review. - GBA1 and The Immune System: A Potential Role in Parkinson's Disease?
Al-Azzawi ZAM, Arfaie S, Gan-Or Z. Al-Azzawi ZAM, et al. J Parkinsons Dis. 2022;12(s1):S53-S64. doi: 10.3233/JPD-223423. J Parkinsons Dis. 2022. PMID: 36057834 Free PMC article. Review. - Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB.
Wilkinson FL, Holley RJ, Langford-Smith KJ, Badrinath S, Liao A, Langford-Smith A, Cooper JD, Jones SA, Wraith JE, Wynn RF, Merry CL, Bigger BW. Wilkinson FL, et al. PLoS One. 2012;7(4):e35787. doi: 10.1371/journal.pone.0035787. Epub 2012 Apr 27. PLoS One. 2012. PMID: 22558223 Free PMC article. - Autophagic- and Lysosomal-Related Biomarkers for Parkinson's Disease: Lights and Shadows.
Xicoy H, Peñuelas N, Vila M, Laguna A. Xicoy H, et al. Cells. 2019 Oct 25;8(11):1317. doi: 10.3390/cells8111317. Cells. 2019. PMID: 31731485 Free PMC article. Review. - Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease.
Donald A, Björkvall CK, Vellodi A; GAUCHERITE Consortium; Cox TM, Hughes D, Jones SA, Wynn R, Machaczka M. Donald A, et al. Orphanet J Rare Dis. 2022 Jun 18;17(1):234. doi: 10.1186/s13023-022-02378-7. Orphanet J Rare Dis. 2022. PMID: 35717194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous